Clave Capital

Activity from announced rounds

Activity in this selectionOct 6, 2026 · AI · Jan 1, 2026
Rounds participated in
1
Confirmed lead rounds
—
1 roles undisclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$7.1M
1 disclosed · full round size, not this investor’s share

By stage

Growth1

By primary sector

Biotech1

By country

Spain1

Rounds

1 in this selection
Pharmacelera

Pharmacelera uses quantum-mechanics methods and AI in drug discovery.

€6MGrowth
Role not disclosed